Bianca Mostert

Bianca Mostert is a researcher in the Department of Medical Oncology at Erasmus MC, a premier academic medical institution in the Netherlands. Her work is deeply embedded in clinical and translational oncology, with a focus on gastrointestinal malignancies, especially esophageal and gastric cancers. She plays a key role in major clinical trials such as the SANO trial, which investigates active surveillance as an alternative to surgery in patients with complete clinical response after neoadjuvant therapy.

Her research interests span Medical Oncology, Esophageal Cancer, Chemoradiotherapy, Clinical Trials, and Cancer Survival Analysis. She is particularly interested in evaluating treatment outcomes, pathological responses, and innovative strategies for treatment de-escalation in cancer care. Her work often involves collaboration with the Rotterdam Oesophageal Tumour Study Group and national consortia.

The recent publication trends highlight her focus on high-impact clinical trials, surrogate endpoints in oncology, and population-based studies. Her articles frequently appear in top-tier journals such as The Lancet Oncology and British Journal of Surgery, covering themes like non-inferiority trial design, multimodal therapy, and prognostic modeling in gastrointestinal cancers.

Scientific Awards:

• No awards listed in the provided text.

Advising and Grants: Bianca Mostert has supervised at least one doctoral thesis, indicating her involvement in training the next generation of researchers. While specific grant details are not mentioned, her participation in large-scale, multicenter trials like SANO suggests involvement in competitively funded research projects.

Labs and Teams: She is actively associated with the Rotterdam Oesophageal Tumour Study Group and the SANO study group, collaborative networks dedicated to improving outcomes in esophageal cancer through evidence-based research.